Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Take 25 percent off your entire order.


* 25% off Holiday Sale: offer valid 11/26/15-1/04/2016. Only valid for purchases by individual U.S., Mexico, Central & South America and Caribbean customers at Current prices and offers subject to change without notice. Offers are not valid on Institutional Video Series, HESI Products, Kindle or Nook e-books, mobile apps, medical clothing or accessories or previous purchases. Offers cannot be combined with each other. Enter promotional code BBV2E16515 at checkout to receive your discount. This offer expires on January 4, 2016.

Cancer Letters

An international journal providing a forum for original and pertinent contributions in cancer research

Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine.

Cancer Letters now offers online submission for authors. Please submit manuscripts at click here and follow the instructions on the site.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: click here

View all Oncology titles

Related Links

Editor Information

    M. Schwab

Impact Factor

* 2011 Journal Citation ReportsĀ®, published by Thomson Reuters

Customer Reviews

Cancer Letters
  • Journal
  • Imprint: ELSEVIER
  • ISSN: 03043835
  • 2014 Impact Factor: 5.621*